Marshall Wace’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
20,900
-151,105
-88% -$9.93M ﹤0.01% 2058
2026
Q1
$12.2M Buy
172,005
+133,814
+350% +$10.6M 0.01% 883
2025
Q4
$3.13M Buy
+38,191
New +$2.98M ﹤0.01% 1369
2025
Q2
Sell
-150,316
Closed -$12.1M 2873
2025
Q1
$12.1M Sell
150,316
-90,397
-38% -$7.77M 0.02% 699
2024
Q4
$18.8M Buy
240,713
+44,180
+22% +$3.76M 0.02% 567
2024
Q3
$18.4M Sell
196,533
-620,195
-76% -$52.1M 0.02% 533
2024
Q2
$63.6M Buy
+816,728
New +$66.6M 0.09% 223
2023
Q3
Sell
-280,708
Closed -$22.8M 2372
2023
Q2
$22.8M Buy
+280,708
New +$22.4M 0.04% 434

Other funds holding GEHC

Marshall Wace's GEHC Position: Q2 2026 in Review

Marshall Wace reduced its GE HealthCare (GEHC) stake by 88% in Q2 2026, selling an estimated $9.93M and leaving 20,900 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

Marshall Wace first reported a position in GEHC in Q2 2023 and has held it in 8 quarters since. The position peaked at $63.6M in Q2 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Marshall Wace held 20,900 shares of GE HealthCare worth $1.34M as of Q2 2026.
  • Marshall Wace sold 151,105 GE HealthCare shares in Q2 2026, an estimated $9.93M.
  • GE HealthCare made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2058 holding.
  • Marshall Wace first reported a position in GE HealthCare in Q2 2023 and has held it in 8 quarters since.
  • Marshall Wace's GE HealthCare position peaked at $63.6M in Q2 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.